Clinical Trial Questions Benefits of Glucocorticoid for Sudden Hearing Loss
A clinical study found that high-dose glucocorticoids are no more effective than a standard-dose in treating those with sudden hearing loss.
Tag: clinical trials
All
Latest
All
Latest
Sensorion, Cochlear Ltd Start Pilot Study for SENS-401
Sensorion and Cochlear Limited (ASX:COH), announce the initiation of a pilot study of the first-in-class small molecule drug SENS-401 (Arazasetron) in patients scheduled for cochlear implantation.
All
Latest
Sensorion Announces Updated Timelines for Phase 2 Study of Hearing Loss Drug
Sensorion (FR0012596468 – ALSEN) a clinical-stage biotech company which specializes in the...
Otonomy Presents Data on OTO-413 Therapy for Hearing Loss
These preclinical data, demonstrating the potential of intratympanic BDNF to repair cochlear synaptopathy—an underlying cause of hearing loss including speech-in-noise hearing difficulty—are being presented as part of the Society for Neuroscience (SfN) Annual Meeting in San Diego, November 3-7, 2018.
Read More
NF2 Trial: An Interview with Rick Friedman, MD, PhD
Hearing Review interviewed Rick Friedman, MD, PhD, about NF2 and an NF2 clinical that is underway in Los Angeles and at 12 other sites in the US. The trial uses the chemotherapy drug Avastin (bevacizumab) as a potential therapy for shrinking NF2 tumors, or stemming their growth.
Read More
Drug Trial Results Offer Hope for Ménière’s, Tinnitus Patients
Otonomy, which develops and commercializes therapeutics for ear diseases and disorders, reported that its development of investigational drugs to help patients with Ménière’s disease and tinnitus, have had positive results in clinical trials.
Read More
Auris Medical Begins Phase 3 Trial for Sudden Deafness Drug
Auris Medical announced it has initiated patient enrollment in the ASSENT Phase 3 clinical trial of AM-111, a drug for treating idiopathic sudden sensorineural hearing loss, or sudden deafness. The drug must be administered within 72 hours after onset of hearing loss.
Read More
Clinical Trial Tests Remote Care for Cochlear Implant Users
The University of Southampton Auditory Implant Service has launched a new clinical trial involving 60 patients, half of whom will use an online care package to determine whether the routine annual clinic check-up of hearing and device status can be replaced with a personalized online version.
Read More
Auris Medical Enrolls First Patient in HEALOS Trial of Hearing Loss Drug
Auris Medical Holding AG, a Swiss biopharmaceutical company, announced enrollment of the first patient into the HEALOS clinical trial to test the drug, AM-111, as a therapy for sudden hearing loss. The trial involves 255 patients suffering from acute severe to profound hearing loss within 72 hours from onset.
Read More
Magnetic Pulses to Brain Bring Relief for Tinnitus Patients
More than half the participants who completed TMS sessions on 10 consecutive workdays found their tinnitus symptoms were alleviated for at least six months.
Read More
Auris Medical Collaborates with Cochlear on Clinical Trial
Auris Medical Holding and Cochlear Limited announced they will collaborate on a planned randomized placebo-controlled clinical trial in the US (the REACH trial) to investigate otoprotection during cochlear implant (CI) surgery.
Read More
Auris Medical Publishes on New Tinnitus Drug
Auris Medical, a Switzerland-based clinical-stage company developing therapeutics for hearing conditions, announced publications in two peer-reviewed journals related to AM-101, the company’s drug developed for treating acute inner ear tinnitus.
Read More
New Drugs for Hearing Loss Expected in 5 Years
According to the 2015 Hearing Progress Report from Action on Hearing Loss (formerly RNID), the first drugs to treat or prevent hearing conditions could be available in 5 years.
Read More
ABI Trial Helps Children Born without Hearing Nerve
Hearing experts at the University of Southern California’s Keck School of Medicine and other institutions are conducting an ABI trial aimed at helping children born without a hearing nerve.
Read More
New York Times: New Drug Studies Target Ear and Balance Ailments
A January 9, 2015 New York Times article reviews pharmaceutical companies’ pursuit of drug therapies for ear and balance ailments, including hearing loss, tinnitus, vertigo.
Read More
Clinical Trial on the Effectiveness of Widex Zen Therapy for Tinnitus
The results from this clinical study strongly support the use of Widex Zen Therapy in tinnitus patient management. This individualized comprehensive approach combining counseling (instructional and adjustment-based cognitive behavioral intervention), amplification, fractal tones and/or noise, and relaxation strategies was highly effective in reducing tinnitus handicap in a short period of time, with improvements apparent through at least the 6-month duration of this investigation.
Read More
Child Hears Sound in First FDA-Approved Clinical Trial of ABI in the US
A three-year-old is the first child in the United States to undergo an auditory brainstem implant surgery in an FDA-approved trial supported by a National Institutes of Health clinical trial grant.
Read More
Henry Ford Health Seeks Tinnitus Sufferers for Two Clinical Trials
Henry Ford Health System in Detroit, Michigan has launched two clinical trials for tinnitus, a chronic ringing of the ears that affects more than 600 million people worldwide.
Read More